Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nalmefene Efficacy Study II: Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy Study of 20 mg Nalmefene, as Needed Use, in Patients With Alcohol Dependence.

Next Previous
Trial Profile

Nalmefene Efficacy Study II: Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy Study of 20 mg Nalmefene, as Needed Use, in Patients With Alcohol Dependence.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nalmefene (Primary)
  • Indications Alcohol withdrawal
  • Focus Registrational; Therapeutic Use
  • Acronyms ESENSE2
  • Sponsors Lundbeck A/S

Most Recent Events

  • 09 Jun 2016 Results of a predictive microsimulation model assessing public health benefits of nalmefene and psychosocial support for the reduction of alcohol consumption from ESENSE1, ESENSE2 and SENSE trials published in the Applied Health Economics and Health Policy
  • 09 Oct 2013 Pooled results for treatment response and quality of life measures in patients with high drinking risk level presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
  • 09 Oct 2013 Pooled results for treatment adherence in patients with high drinking risk level presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top